Sanofi stops all but the most urgent trips to China; Flurry of orphan drug designations arrive
→ Over at Novartis execs rolled their Q4 numbers out with calming words about any effect the Wuhan virus outbreak could be having on operations …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
